Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BioLink-2022 by Protheragen for Congestive Heart Failure (Heart Failure): Likelihood of Approval
BioLink-2022 is under clinical development by Protheragen and currently in Phase I for Congestive Heart Failure (Heart Failure). According to...